Diabetic peripheral neuropathic pain Trials in Dallas, United States
Conditions / Diabetic peripheral neuropathic pain / Dallas, United States
Diabetic peripheral neuropathic pain has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04476108 | Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain | COMPLETED | PHASE2 |
| NCT06893094 | A Phase 2 Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain | TERMINATED | PHASE2 |
| NCT06696443 | Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05177094 | Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain | COMPLETED | PHASE2 |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | — |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | — |
| NCT05895552 | A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain | TERMINATED | PHASE2 |
| NCT06619860 | Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy | RECRUITING | — |
| NCT00838799 | Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain | COMPLETED | PHASE2 |
| NCT06203002 | A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) | COMPLETED | PHASE2 |